Review Special Issues

The disruption of proteostasis in neurodegenerative disorders

  • Received: 01 April 2015 Accepted: 01 June 2015 Published: 07 June 2015
  • Cells count on surveillance systems to monitor and protect the cellular proteome which, besides being highly heterogeneous, is constantly being challenged by intrinsic and environmental factors. In this context, the proteostasis network (PN) is essential to achieve a stable and functional proteome. Disruption of the PN is associated with aging and can lead to and/or potentiate the occurrence of many neurodegenerative diseases (ND). This not only emphasizes the importance of the PN in health span and aging but also how its modulation can be a potential target for intervention and treatment of human diseases.

    Citation: Ana Jalles, Patrícia Maciel. The disruption of proteostasis in neurodegenerative disorders[J]. AIMS Molecular Science, 2015, 2(3): 259-293. doi: 10.3934/molsci.2015.3.259

    Related Papers:

    [1] Moshe Rosenberg, Yael Rosenberg . Proteolysis during aging of commercial full-fat and reduced-fat Cheddar cheeses of identical chronological age. AIMS Agriculture and Food, 2022, 7(4): 855-871. doi: 10.3934/agrfood.2022052
    [2] Emmanuel Hanyabui, Samuel Obeng Apori, Kwame Agyei Frimpong, Kofi Atiah, Thomas Abindaw, Muhammed Ali, Joshua Yeboah Asiamah, John Byalebeka . Phosphorus sorption in tropical soils. AIMS Agriculture and Food, 2020, 5(4): 599-616. doi: 10.3934/agrfood.2020.4.599
    [3] Graciela Ivette Béjar-Lio, Néstor Gutiérrez-Méndez, Guadalupe Virginia Nevárez-Moorillón . Microbiological and physicochemical characteristics of Chihuahua cheese manufactured with raw milk. AIMS Agriculture and Food, 2020, 5(1): 86-101. doi: 10.3934/agrfood.2020.1.86
    [4] Eleni C. Pappa, Efthymia Kondyli, Anna-Maria Vlachou, Athanasia Kakouri, Evdokia Malamou, John Samelis . Semi industrial production of Tsalafouti dairy product. AIMS Agriculture and Food, 2022, 7(2): 444-460. doi: 10.3934/agrfood.2022028
    [5] Aliou Badara Kouyate, Vincent Logah, Robert Clement Abaidoo, Francis Marthy Tetteh, Mensah Bonsu, Sidiki Gabriel Dembélé . Phosphorus sorption characteristics in the Sahel: Estimates from soils in Mali. AIMS Agriculture and Food, 2023, 8(4): 995-1009. doi: 10.3934/agrfood.2023053
    [6] Francisco L. Pérez . Viticultural practices in Jumilla (Murcia, Spain): a case study of agriculture and adaptation to natural landscape processes in a variable and changing climate. AIMS Agriculture and Food, 2016, 1(3): 265-293. doi: 10.3934/agrfood.2016.3.265
    [7] Budi Suarti, Sukarno, Ardiansyah, Slamet Budijanto . Bio-active compounds, their antioxidant activities, and the physicochemical and pasting properties of both pigmented and non-pigmented fermented de-husked rice flour. AIMS Agriculture and Food, 2021, 6(1): 49-64. doi: 10.3934/agrfood.2021004
    [8] Sapta Raharja, Yogi Purna Rahardjo, Samsudin, Khaswar Syamsu . Aroma precursor enhancing in dried cocoa beans fermentation using enzyme and heat addition. AIMS Agriculture and Food, 2023, 8(2): 674-686. doi: 10.3934/agrfood.2023037
    [9] Artyom Lamanov, Yurij Ivanov, Rishat Iskhakov, Liliya Zubairova, Khamit Tagirov, Azat Salikhov . Beef quality indicators and their dependence on keeping technology of bull calves of different genotypes. AIMS Agriculture and Food, 2020, 5(1): 20-29. doi: 10.3934/agrfood.2020.1.20
    [10] Siti Hajar Othman, Nazirah Mohd Rosli, Norhazirah Nordin, Masturina Abdul Aziz . Formulation of crispy chicken burger patty batter: Properties and storage qualities. AIMS Agriculture and Food, 2022, 7(2): 426-443. doi: 10.3934/agrfood.2022027
  • Cells count on surveillance systems to monitor and protect the cellular proteome which, besides being highly heterogeneous, is constantly being challenged by intrinsic and environmental factors. In this context, the proteostasis network (PN) is essential to achieve a stable and functional proteome. Disruption of the PN is associated with aging and can lead to and/or potentiate the occurrence of many neurodegenerative diseases (ND). This not only emphasizes the importance of the PN in health span and aging but also how its modulation can be a potential target for intervention and treatment of human diseases.


    The textural, sensorial and functional quality attributes of Cheddar cheese evolve during the aging of the cheese and reflect the combined influence of the dynamic microbiological, biochemical, and physico-chemical activities and reactions [1,2,3,4]. The main three biochemical cascades that occur during cheese aging are glycolysis, lipolysis and proteolysis [2,5,6]. Among these, proteolysis is considered the most important and most complex series of events [2,7,8]. The proteolytic cascade that occurs during cheese aging consists of enzymatic degradation of the casein constituents of the cheese matrix and the accumulation of a very heterogeneous population of peptides of different molecular weights and free amino acids [5,6,9,10]. A certain proportion of these free amino acids becomes involved in catabolic reactions the products of which have a major impact on the flavor and aroma characteristics of the cheese [5,10,11]. The type, rate, and extent of the proteolytic activities that occur during the aging of Cheddar cheese are governed by combined effects of the type and concentration of proteolytic agents that are included in the curd, curd composition, and the aging conditions [2,5,6]. The proteolytic agents in Cheddar cheese produced with pasteurized milk include the indigenous proteolytic enzymes of milk, plasmin and cathepsin D, heat-stable proteolytic enzymes of somatic cells and psychrotrophic bacteria, the proportion of milk coagulant that is retained in the curd, as well as the proteolytic enzymes of starter- and non-starter lactic acid bacteria [6,7,12,13,14,15,16,17,18]. The dynamics of the proteolytic activities during cheese aging are governed by the combined effects of curd composition, pH, salt-in-moisture (S/M), ionic strength and ionic composition [2,5,19,20]. Cheddar cheese is commonly aged isothermally at 6-8 ℃ [21] and the effect of aging temperature on proteolysis during cheese aging has been recognized and has been exploited as an effective means for accelerating cheese aging [6,21,22,23,24,25,26,27,28,29,30,31]. For example, Cheddar cheese that had been aged at different time-at-temperature programs at temperatures ranging from 7 to 20 ℃ exhibited significant time-at-temperature-dependent differences in microstructural, textural, and sensorial characteristics that reflected the effect of the aging conditions on the extent of proteolysis [21,26]. Aging Cheddar cheese at an elevated temperature allows enhancing its aging process, however, it can also lead to the evolution of microbiological, textural and sensorial defects [6,30,31]. It has been suggested that an accelerated aging temperature of 12 ℃ is optimal in order to limit adverse effects of high aging temperature on proteolysis and, consequently, texture and flavor [23,24,30]. The information about the effects of non-isothermal aging conditions on proteolysis is relatively limited and has been established for cheeses that had been subjected to temperatures higher than 10 ℃ [21,26]. Mitigating challenges that are associated with disrupt supply chain are likely to require modulating the rate of cheese aging without introducing a major acceleration effect that are known to lead to the evolution of textural and sensorial defects [24]. Introducing such capabilities requires developing information about the effects of relatively small changes in aging temperature on proteolysis. Additionally, it has to be recognized that, unfortunately, maintaining isotropic temperature distribution in cheese aging rooms is a common challenge and cheeses that are stored at different domains in a given aging room experience different time-at-temperature conditions. Recently, it has been demonstrated that both an electronic nose and consumers could detect sensorial differences between Cheddar cheeses that had been aged at 10 ℃ and 7 ℃ [27]. Data about the extent to which small variations in aging temperature affect proteolysis during aging of Cheddar cheese has been established only to a very limited extent. The objective of our research was to age FF and RF Cheddar cheeses at different time-at-temperature aging regimes ranging from 5 to 8 ℃ and to investigate the effects of these conditions on proteolysis during 6 months of aging.

    Ten-day old full-fat (FF) and reduced-fat (RF) Cheddar cheeses were delivered, at 4-6 ℃, to our laboratory. Both cheeses were manufactured on the same day from the same batch of pooled milk, using the same coagulant and starter cultures, at a California creamery. Immediately upon arrival, the cheeses were cut into 1 kg portions that were then vacuumed packaged in BK1 Cryovac plastic bags (W.R. Grace Co., Duncan, SC). The packaged cheeses were aged for 180 days at different isothermal and non-isothermal time-at-temperature programs (Table 1). Cheeses were denoted according to their type (FF or RF) and the time-at-temperature program at which they were aged. For example, FF5 and RF8 were full-fat and reduced-fat Cheddar cheeses that were aged for 180 at 5 and 8 ℃, respectively. Similarly, FF585AC was a full-fat Cheddar cheese that was aged for 30 days at 5 ℃ than for 60 days at 8 ℃, and for additional 90 days at 5 ℃.

    Table 1.  Time-at-temperature details of the aging programs.
    Program Time-at-temp details
    5 Isothermal aging at 5 ℃ for 180 days
    5-8 A 30 days at 5 ℃ and then 150 days at 8 ℃
    5-8 B 60 days at 5 ℃ and then 120 days at 8 ℃
    5-8-5 AB 30 days at 5 ℃, 30 days at 8 ℃, and then 120 days at 5 ℃
    5-8-5 AC 30 days at 5 ℃, 60 days at 8 ℃, and then 90 days at 5 ℃
    8 Isothermal aging at 8 ℃ for 180 days
    8-5 A 30 days at 8 ℃ and then 150 days at 5 ℃
    8-5 B 60 days at 8 ℃ and then 120 days at 5 ℃
    8-5-8 AB 30 days at 8 ℃, 30 days at 5 ℃, and then 120 days at 8 ℃
    8-5-8 AC 30 days at 8 ℃, 60 days at 5 ℃, and then 90 days at 8 ℃

     | Show Table
    DownLoad: CSV

    The moisture, protein, fat, ash and salt contents of the FF and RF cheeses were determined at a cheese age of 10 days according to the Standard Methods of analyzing milk and dairy products [32]. Moisture content was determined gravimetrically, after vacuum drying for 12 h [32]. Protein content was determined according to the macro-Kjeldahl method, using a nitrogen-to-protein conversion factor of 6.38 [32]. Fat content was determined according to the Rose-Gotlieb method and ash content was determined gravimetrically after incineration in a muffle furnace at 550 ℃ [32]. Salt content of the cheeses was determined according to the Volhard method [32]. The results of the latter analysis and those of the afore-mentioned moisture content analysis were used to calculate the concentration (%) of salt in the aqueous phase of the cheese, that is salt-in-moisture (S/M). The pH of the investigated cheeses was determined using an Orion Star pH meter equipped with a spear-tip glass electrode (Thermo- Fisher Scientific). In all cases, duplicate samples were analyzed in triplicate (N X n = 6).

    The effects of the investigated aging programs on proteolysis during cheese aging were investigated by monitoring the accumulation of three cheese-N fractions that has been indicated as cheese aging indices [7,33]. These consisted of the cheese-N fraction that was soluble at pH 4.6 (pH 4.6SN), the Cheese-N fraction that was soluble in 12% tri-chloroacetic acid (12TCASN) and that Cheese-N fraction that was soluble in 5% Phospho-tungstic acid (5PTASN) [7,33,34,35,36]. The investigated cheese fractions were prepared as previously described, with some modifications [9,33,34,35]. Briefly, grated cheese (200 g) was mixed with 400 mL of de-ionized water (Millipore, 18.2 MW.cm) and the mixture was homogenized for 3 min using a model 34BL97 Warning Blender (Dynamic Corp., New Hartford, CT) operated at maximum speed. The homogenate was stirred for 30 min at 25 ℃ and was then centrifuged for 20 min at 3000 X g. The supernatant was filter through a layer of glass wool (Fisher Scientific, Fair Lawn, NJ) and the pH of the filtrate was adjusted to pH 4.6 using 1.4N HCl. The mixture was centrifuged for 20 min at 3000 X g and, the supernatant was filtered through a Number 1 Whatman filter paper (Fisher Scientific, Fair Lawn, NJ). The filtrate was denoted as pH 4.6-soluble N (pH 4.6SN). A portion (45 mL) of the pH4.6SN fraction was mixed with 15 mL of 48% (w/v) TCA (Sigma Chemical Co., St. Luis, MO). The mixture was incubated at 25 ℃ for 12 h and was then centrifuged for 20 min at 3000 X g. The supernatant was filtered through No1 Whatman filter paper and the filtrate was denoted 12%TCA-soluble N (12TACSN). The cheese N fraction that was soluble in 5% PTA was preparing by mixing 50 mL of the 4.6SN fraction with 3.95 mL of H2SO4 and 15 mL of 33.3% (w/w) PTA (Sigma Chemical Co. St. Luis, MO). After incubation for 12 h at 25 ℃, the mixture was centrifuged at 3000 X g for 20 min, the supernatant was filtered through a No1 Whatman filter paper and the filtrate was denoted as 5% PTA-soluble N fraction (5PTASN). In all cases, the N content of the afore-mentioned fractions was determined by the macro-Kjeldhal analysis and the results were expressed as percent of total cheese N. In all cases, duplicate samples were analyzed in triplicates (N x n = 6).

    The significance of the resulted was challenged, at p < 0.05, by ANOVA using the SigmaStat software (Jandel Scientific Software, San Rafael, CA, USA). Line equations were established using the trendline tools included in Microsoft Excel software package (Microsoft Office Professional Plus 2016 (Microsoft, Redmond, WA, USA).

    The composition of the 10d old cheeses is detailed in Table 1. The fat and protein content of the RF cheese was about 33% lower and 28% higher than that of the FF Cheddar, respectively (Table 1). The pH of the two cheeses did not differ significantly (p > 0.05) and the S/M content of the RF cheese was significantly higher (p < 0.05) than that in the FF cheese. In the case of Cheddar cheese, the S/M is adjusted to be at least 4.5%. A lower S/M can promote an excessive extent of proteolysis that, in many cases can lead to the accumulation of bitter peptide originating mainly from β-CN [37]. Reduced- and low-fat Cheddar cheeses have been reported to be prone to the evolution of higher-than desired lactic acid content during cheese making [38]. The similar pH of the cheeses at 10 days of age suggested that the RF cheese had been produced at conditions that prevented the excessive evolution of the pH. Alternatively, the similar pH can be explained in light of the higher protein content of the RF cheese that presented a higher buffering capacity than that in the FF cheese [9,38].

    At a cheese age of 10 d, prior to being subjected to the different time-at-temperature aging conditions, the proportion of pH 4.6SN in the FF cheese was 14.6% higher than that in the RF cheese (Table 2). The proportions of the 12TCASN and of the 5PTASN in the 10d old FF Cheddar was 21.3 and 23.1% higher than that in the 10d old RF cheese, respectively (Table 2). Results thus indicated that overall, at the age of 10 days, the FF Cheddar exhibited a higher extent of proteolysis than that RF cheese. Because both cheeses were manufactured from the same batch of milk, this result can be probably attributed to the lower S/M of the FF cheese that allowed a higher extent of mainly primary proteolysis during the first 10 days following cheese making [9,39].

    Table 2.  Composition of the 10d old FF and RF Cheddar cheeses.
    Constituent FF Cheddar RF Cheddar
    Moisture (%) 39.12 ± 0.41 43.93 ± 0.39
    Fat (%) 32.80 ± 0.46 21.66 ± 0.25
    Protein (%) 22.50 ± 0.23 28.83 ± 0.56
    Ash (%) 4.21 ± 0.11 3.99 ± 0.02
    Salt (%) 1.46 ± 0.02 1.98 ± 0.03
    S/M (%) 3.70 ± 0.04 4.50 ± 0.04
    pH 5.16 ± 0.05 5.10 ± 0.05
    pH4.6 SN (% TN) 6.35 ± 0.31 5.54 ± 0.21
    12TCASN (% TN) 3.36 ± 0.31 2.77 ± 0.21
    5PTA (% TN) 1.12 ± 0.05 0.91 ± 0.05

     | Show Table
    DownLoad: CSV

    The results (Tables 3-9) have to be assessed in light of the different proteolytic activities that occur at different stages of the aging process. In general, at any given time, the level of each of the investigated cheese fractions represented the overall balance between proteolytic events that continuously hydrolyzed the cheese caseins, throughout the 180 aging days, and the involvement of free amino acids from the pool of the accumulated proteolytic products, in catabolic reactions [10,36]. Changes, with aging time, in the level of the accumulation of the investigated fractions represented the manifestation of different enzymatic and microbiological activities at different stages of the aging process as well as the effects of cheese composition and aging conditions on these events [2,5]. At early stages of the aging, proteolysis is mainly governed by the activity of the residuals of the coagulant that have been retained in the curd, plasmin, heat-stable proteases that are associated with somatic cells and psychrotrophic bacteria, and the extracellular, cell envelope-associated proteinase of Lactococccus [2,7]. At later stages, after the starter and non-starter lactic acid bacteria undergo autolysis, proteolytic products that have accumulated inside the bacterial cells as well as the microbial proteases and peptidases are released into the curd [7,11,40]. The activity of the latter becomes a significant contributor to the proteolytic cascade that result in the continuous accumulation of a very heterogeneous population of peptides and free amino acids, pending the consumption of the cheese [5,7,8,10,11].

    Table 3.  Line equations describing the accumulation of the investigated cheese-N fractions during isothermal aging of FF and RF cheeses at 5 ℃ and 8 ℃.
    Cheese/fraction Line equation R2
    FF8/pH4.6SN Y=3E − 06X3 − 0.0012X2 + 0.2165X + 4.7492 0.9878
    FF5/pH4.6SN Y=3E − 06x3 − 0.0013x2 + 0.1957x + 4.7001 0.9938
    RF8/ pH4.6SN Y=4E − 06X3 − 0.0016X2 + 0.2778X + 3.4744 0.9867
    RF5/ pH4.6SN Y=1E − 06X3 + 3E − 05X2 + 0.1155X + 4.4373 0.9895
    FF8/12TCASN Y=−9E − 0.5X2 + 0.077X + 3.0278 0.9837
    FF5/12TCASN Y=−7E − 05X2 + 0.0461X + 3.4024 0.9610
    RF8/ 12TCASN Y=−0.0002X2 + 0.0994X + 1.9454 0.9945
    RF5/ 12TCASN Y=−6E − 05X2 + 0.0539X + 2.2018 0.9933
    FF8/5PTASN Y=5E − 05X2 + 0.0144 + 1.1231 0.9907
    FF5/5PTASN Y=−5E − 05X2 + 0.0236X + 0.9558 0.9961
    RF8/ 5PTASN Y=−E5 − 05X2 + 0.0305X + 0.6071 0.9983
    RF5/ 5PTASN Y=1E − 05X2 + 0.0089X + 0.8204 0.9928

     | Show Table
    DownLoad: CSV
    Table 4.  Changes in the proportion of pH 4.6-SN (% of TN) during aging of FF Cheddar cheese at different aging programs.
    Program pH4.6SN (% of TN)
    30 days 60 days 90 days 120 days 180 days
    5 9.82b 12.54b 13.76d 15.56e 17.07e
    5-8A 9.82b 13.77a 15.98b 17.23c 20.31c
    5-8B 9.82b 12.54b 13.92d 15.65e 19.91c
    5-8-5AB 9.82b 13.77a 15.98b 15.60e 18.63d
    5-8-5AC 9.82b 13.77a 15.98b 16.98c 20.06c
    8 11.15a 13.94a 16.05b 19.43a 22.41a
    8-5A 11.15a 12.35b 14.84c 17.34c 20.42c
    8-5B 11.15a 13.94a 16.70a 18.44b 21.37b
    8-5-8AB 11.15a 12.35b 15.71b 16.92c 20.05c
    8-5-8C 11.15a 12.35b 14.84c 16.56d 20.12c
    abcdeFor a given column, means that are followed by different letters differ significantly (p < 0.05).

     | Show Table
    DownLoad: CSV
    Table 5.  Changes in the proportion of pH 4.6-SN during aging of RF Cheddar cheese at different aging programs.
    Program pH 4.6SN (% of TN)
    30 d 60 d 90 d 120 d 180 d
    5 8.16b 10.51c 14.92d 16.10e 18.55f
    5-8 A 8.16b 13.78a 16.57b 18.88b 23.47a
    5-8 B 8.16b 10.51c 14.31d 19.50b 22.71b
    5-8-5 AB 8.16b 13.78a 15.49c 16.90d 18.31f
    5-8-5 AC 8.16b 13.78a 16.57b 19.20b 20.37e
    8 11.71a 14.17a 18.10a 20.47a 23.86a
    8-5 A 11.71a 13.92a 14.52d 15.70e 18.78ef
    8-5 B 11.71a 14.17a 15.85c 17.33c 19.14e
    8-5-8 AB 11.71a 13.90a 15.70c 18.89b 22.23c
    8-5-8 AC 11.71a 13.92a 14.52d 17.76c 21.32d
    abcdefFor a given column, means that are followed by different letters differ significantly (p < 0.05).

     | Show Table
    DownLoad: CSV
    Table 6.  Changes in the proportion of 12% TCA-SN during aging of FF Cheddar cheese at different aging programs.
    Program 12TCASN (% of TN)
    30 days 60 days 90 days 120 days 180 days
    5 5.33b 6.20c 6.61e 7.79f 9.53g
    5-8 A 5.33b 6.89b 8.98c 10.76a 13.40b
    5-8 B 5.33b 6.20c 8.23d 9.21e 13.26b
    5-8-5 AB 5.33b 6.89b 8.85c 9.52d 10.07f
    5-8-5 AC 5.33b 6.89b 8.98c 9.78c 10.52e
    8 5.84a 7.18a 9.69a 10.35b 14.15a
    8-5 A 5.85a 6.73c 8.42d 9.32e 10.72f
    8-5 B 5.85a 7.18a 8.50d 9.23e 10.93d
    8-5-8 AB 5.85a 6.73b 9.36b 10.49b 13.46b
    8-5-8 AC 5.85a 6.73b 8.42d 9.42d 11.54c
    abcdefgFor a given column, means that are followed by different letters differ significantly (p < 0.05).

     | Show Table
    DownLoad: CSV
    Table 7.  Changes in the proportion of 12% TCA-SN during aging of RF Cheddar cheese at different aging programs.
    Program 12TCASN (% of TN)
    30 d 60 d 90 d 120 d 180 d
    5 3.70a 5.11d 6.94c 7.52c 9.00f
    5-8 A 3.70a 6.50b 7.88b 9.15b 12.06b
    5-8 B 3.70a 5.11d 7.88b 9.42b 11.70c
    5-8-5 AB 3.70a 6.50b 7.25c 8.41b 9.70e
    5-8-5 AC 3.70a 6.50b 7.88b 9.30b 10.46d
    8 4.99b 6.90a 9.53a 10.47a 12.95a
    8-5 A 4.99b 6.27c 7.34c 8.24b 10.36d
    8-5 B 4.99b 6.90a 7.45b 9.53b 9.22f
    8-5-8 AB 4.99b 6.27c 7.83b 10.05a 11.41d
    8-5-8 AC 4.99b 6.27c 7.34c 8.73b 10.40d
    abcdefFor a given column, means that are followed by different letters differ significantly (p < 0.05).

     | Show Table
    DownLoad: CSV
    Table 8.  Changes in the proportion of 5% PTA-SN (% of TN) during aging of FF Cheddar cheese at different aging programs.
    Program 5PTASN (% of TN)
    30 d 60 d 90 d 120 d 180 d
    5 1.71a 2.22a 2.63c 3.09c 3.65d
    5-8 A 1.71a 2.05a 2.91ab 3.55a 4.84b
    5-8 B 1.71a 2.22a 2.43d 2.50e 4.72b
    5-8-5 AB 1.71a 2.05a 3.01a 3.45a 4.20c
    5-8-5 AC 1.71a 2.05a 2.91ab 3.22b 3.84d
    8 1.77a 2.20a 2.86ab 3.33b 5.28a
    8-5 A 1.77a 1.97a 2.68c 3.02c 3.47d
    8-5 B 1.77a 2.20a 2.50d 3.32b 3.81d
    8-5-8 AB 1.77a 1.97a 3.11a 3.33b 4.75b
    8-5-8 AC 1.77a 1.97a 2.68c 2.76d 3.83d
    abcdFor a given column, means that are followed by different letters differ significantly (p < 0.05).

     | Show Table
    DownLoad: CSV
    Table 9.  Changes in the proportion of 5% PTA-SN during aging of RF Cheddar cheese at different aging programs.
    Program 5PTASN (% of TN)
    30 days 60 days 90 days 120 days 180 days
    5 1.12b 1.38d 1.62d 2.13d 2.74c
    5-8 A 1.12b 1.87b 2.35b 2.96c 4.23b
    5-8 B 1.12b 1.38d 2.23b 2.85c 3.83b
    5-8-5 AB 1.12b 1.87b 2.02c 2.16d 2.98c
    5-8-5 AC 1.12b 1.87b 2.35b 3.14b 3.59b
    8 1.43a 2.36a 2.90a 3.55a 4.52b
    8-5 A 1.43a 1.65c 1.85c 2.04d 3.44b
    8-5 B 1.43a 2.36a 2.90a 3.27b 3.93b
    8-5-8 AB 1.43a 1.65c 2.23b 3.65a 4.71a
    8-5-8 AC 1.43a 1.65c 1.85c 2.90c 3.62b
    abcdFor a given column, means that are followed by different letters differ significantly (p < 0.05).

     | Show Table
    DownLoad: CSV

    The two isothermal aging programs to which the cheeses were subjected differed by only 3 ℃ and both temperatures were below 10 ℃. At both isothermal aging programs, the proportion of the pH 4.6SN in both FF and RF cheeses increased with aging time and in all cases its level in the cheeses was proportionally related to the aging temperature (Tables 4 and 5). The changes in the pH 4.6SN with aging time could be best described (R2 = 0.9867-0.9938) by polynomial expressions (Table 3), similar to what has been earlier reported for FF and LF Cheddar cheese [33]. The observed changes in the level of the accumulated pH 4.6SN reflected the overall balance between the extent of primary proteolysis and secondary proteolytic reactions as well as the catabolism of free amino acids [7,11]. After 60, 120 and 180 days, the proportion of pH 4.6SN in the FF8 cheese was about 13.5, 24.9, and 31.3% higher than that in the FF5 cheese, respectively (Table 4). Similarly, in the RF cheeses (Table 5), after 60, 120 and 180 days, the proportion of pH 4.6SN in the cheeses that had been aged at 8 ℃ was 34.8, 27.1, and 28.6%, higher than that in the RF cheeses that had been aged at 5 ℃, respectively. For a given aging time, the differences between FF and RF cheeses in the level of the pH 4.6SN fraction ranged from 4.4 to 20% and from 1.7 to 14.6%, for cheeses aged at 5 ℃ and 8 ℃, respectively (Tables 4 and 5). Results thus indicated that the effect of aging temperature on the extent of proteolytic activities was greater than the effect of cheese composition.

    The changes with aging time in the proportion of the 12TCASN in the isothermally-aged FF and RF cheeses are depicted in Tables 6 and 7, respectively, and the polynomial line equations that best describe these changes (R2 = 0.961-0.9945) are presented in Table 3. The levels of 12TCASN that accumulated in the FF and RF cheeses during aging at 8 ℃ was 1.10-1.50 and 1.29-1.39 times higher than that in the cheeses that were aged at 5 ℃, respectively (Tables 6 and 7). During the first 60 days of aging at 5 ℃, the proportion of 12TCASN that accumulated in the FF cheese was 1.21-1.44 times higher than that accumulated in the RF cheese, however, at a longer aging time, the levels of the 12TCASN differed only slightly between the FF and the RF cheeses (Tables 6 and 7). The accumulation of the 5PTASN fraction was proportionally related to the aging time and the polynomial expressions that best describe (R2 = 0.9928-0.9983) the changes in this fraction with aging time are presented in Table 3. The accumulation of 5PTASN in the RF8 cheese was 1.28-1.79 times higher than that accumulated in the RF5 cheese (Table 9). Throughout the first 120 aging days, the level of 5PTASN in the FF8 cheese differed by less than 10% from that accumulated at FF5 cheese. However, after 180 days, the level of the 5PTASN in the FF8 cheese was 1.45 times higher than that in the FF5 cheese (Tables 8 and 9). The differences in the level of the 5PTASN that accumulated in the FF5 and FF8 cheese varied by 23-63% and by 6.2-16.6% from that in the RF5 and RF8 cheeses, respectively (Tables 8 and 9). The results of the isothermal aging indicated the significant effect that a 3 ℃ difference in aging temperature had on the accumulation of all the investigated cheese-N fractions. The results thus indicated that a 3 ℃ difference in aging temperature effectively and significantly enhanced the proteolytic cascade in both the FF and RF cheeses.

    Eight different non-isothermal time-at-temperature aging regimes were investigated for their effects on the proteolytic cascades that occur during aging of FF and RF Cheddar cheeses. The different aging regimes consisted of two "cold-to-warmer" and two "warm-to-colder" programs, two cold-to-warmer-back to colder" as well as two regimes of "warm-to-colder-back to warmer" regimes. The symmetric design of the aging programs was aimed at assessing the influence of a small change in aging temperature and the impact of the stage, during aging, at which such change is made. In all cases, although the temperature difference between the "warm" and "cold" phases of the aging was 3 ℃, the accumulation of the proteolytic products was affected (p < 0.05) by the combined influence of the aging time-at-temperature details and cheese composition (Tables 4-9). Results (Tables 4-9) indicated that increasing or decreasing the aging temperature by only 3 ℃ significantly affected the proteolytic cascade in the cheese in a way that enhanced or slowed down the accumulation of proteolytic products in the cheese, respectively (p < 0.05). Results of the study also indicated that the stage at which the aging temperature is changed had a significant (p < 0.05) influence on the accumulation of the different proteolytic products (Tables 4-9).

    Increasing the aging temperature from 5 to 8 ℃ enhanced the accumulation of the pH 4.6SN fraction in the cheese, thus indicating the effect of aging temperature on the proteolytic cascade. For example, 30d after increasing the aging temperature by 3 degrees, the pH 4.6SN that accumulated in the FF58A, FF58AB, and FF58AC cheeses was significantly higher (p < 0.05) than that in the FF5 cheese and similar (p > 0.05) to that in the FF8 and the FF85B cheeses (Table 4). Similarly, reducing the temperature from 8 to 5 ℃ slowed down the accumulation of the pH4.6SN, at an aging program-specific manner.

    After 180d, the level of pH 4.6SN that accumulated in the FF cheeses was in the order: FF8 > FF85B > FF85A = FF58A = FF58B = FF585AC = FF858AB = FF858AC > FF585AB > FF5. The accumulation of the pH 4.6SN in the non-isothermally aged RF cheeses was influenced by the time-at-temperature conditions during aging in a way similar to that exhibited by the FF cheeses (Tables 4 and 5). It was interesting to note (Tables 4 and 5) that after 6 aging months, the pH 4.6SN that accumulated in the RF58A cheese was similar to that in the RF8 cheese (p > 0.05) while that in the RF85A cheese was similar to the level that accumulated in the RF5 cheese (p > 0.05).

    After 180d, the level of the pH4.6SN that accumulated in the RF cheeses was in the order: RF8 = RF58A > RF58B > RF858AB > RF858AC > RF85B = RF85A = RF585AC > RF585AB = RF5 (Table 5). Increasing or lowering the aging temperature by 3 ℃ during aging provided an effective means for modulating the accumulation of the pH 4.6WSN in Cheddar cheese and, potentially its aging rate. For example, after 60, 90 and 120 days, the accumulation of pH 4.6SN in the FF58A cheese was similar to that in FF5 cheese after 90, 120, and 180 aging days, respectively (Table 4).

    The pH 4.6SN fraction of cheese consists of a very heterogeneous population of proteolytic products ranging from high-molecular weight peptides to free amino acids [7,8,33]. The composition of the pH 4.6SN fraction changes with aging time in a way that reflects the increasing activities of peptidases that degrade the products of the primary proteolysis, on one hand, and the manifestation of amino acids catabolism, on the other hand [2,7]. The degradation of the products of primary proteolysis by microbial proteases and peptidases has been shown to be reflected in the changes, with aging time, in the accumulation of 12TCASN and 5PTASN fractions [7,8].

    The 12TCASN fraction of cheese contains proteolytic products consisting of medium- and low-MW peptides and free amino acids [7,8]. Results (Tables 6 and 7) indicated that the accumulation of this fraction in the FF and RF Cheddar cheeses was significantly influenced by the aging programs in a time-at-temperature details-specific manner (p < 0.05). For example, 30, 60, 90, and 120d after its aging temperature was increased from 5 to 8 ℃, the level of the 12TCASN fraction in the FF58A was 1.11, 1.35, 1.38, and 1.41 times higher (p < 0.05) than that in FF5 cheese, respectively (Table 6). Similarly, 30, 60, 90, and 120d after its aging temperature was lowered from 8 to 5 ℃, the level of the 12TCASN fraction in the FF85A was 0.88, 0.86, 0.90, and 0.76 times of that accumulated in the FF8 cheese, respectively (Table 6). The accumulation of the 12TCASN in the RF cheeses was also significantly influenced (p < 0.05) by the aging conditions (Table 7). For example, 30, 60, 90, and 120d after its aging temperature was increased from 5 to 8 ℃, the level of the 12TCASN fraction in the RF58A was 1.14, 1.45, 1.22, and 1.34 times higher than that in the RF5 cheese, respectively (Table 7). Lowering the aging temperature from 8 to 5 ℃ slowed down the accumulation of the 12TCASN fraction in the RF cheese. For example, 30, 60, 90, and 120d after its aging temperature was lowered from 8 to 5 ℃, the level of the 12TCASN fraction in the RF85A was 0.90, 0.77, 0.78, and 0.80 of that in the RF8 cheese, respectively (Table 7). In all other cases, for both RF and FF cheeses, the accumulation of the 12TCASN was significantly affected by the combined influence of the stage at which the temperature was changed and by the overall time during which the cheese was aged at 5 and at 8 ℃ (Tables 6 and 7).

    After 180 aging days, the level of the 12TCASN in the RF cheese was in the order: RF8 > RF58A > RF58B > RF585AC = RF85A = RF858AB = RF858AC > RF85B = RF5 (Table 7). After 180 aging days, the level of the 12TCASN that accumulated in the FF cheeses was in the order: FF8 > FF858AB = FF58B = FF58A > FF858AC > FF85B > FF585AC > FF85A = FF585AB > FF5 (Table 6).

    The 5PTASN fraction contains very small peptides of MW up to 600 Da and free amino acids. This fraction represents the pool of free amino acids that can become involved in catabolic reactions that flavor- and aroma-impacting compounds and thus has been identified as indicative of flavor development in cheeses [34]. At a given aging time, the level of 5PTASN represents the balance between the accumulation of small proteolytic products and their disappearance in catabolic reactions [10,11]. For both FF and RF cheeses, the changes, with aging time, in the level of 5PTASN was significantly (p < 0.05) influenced by the time-at-temperature details of the aging program (Tables 8 and 9). In the case of FF cheeses, similar (p > 0.05) levels of 5PTASN accumulated during the first 60 days of aging at all the investigated programs. However, at later stages of the aging, the accumulation of this fraction was significantly influenced by the time-at-temperature conditions (Tables 8 and 9), thus suggesting the increasing contribution, with aging time, of peptidases as well as of proteolytic products that were released into the curd after the lysis of starter and non-starter bacteria in the curd. After 90 and 120d, the level of the 5PTASN in the FF58A, FF58B, FF585AB, and FF585AC was 10-14% and 5-14% higher than that in the FF5 cheese, respectively (Table 8). The accumulation of the 5PTAASN in the RF cheeses was significantly influenced (p < 0.05) by the aging conditions (Table 9). 30, 60, 90, and 120d after its aging temperature was increased from 5 to 8 ℃, the level of the 5PTASN fraction in the RF58A was 1.36, 1.45, 1.38, and 1.71 times higher than that in the FF5 cheese, respectively (Table 9). Lowering the aging temperature from 8 to 5 ℃ slowed down the accumulation of the 5PTASN fraction in the RF cheese. For example, 30, 60, 90, and 120d after its aging temperature was lowered from 8 to 5 ℃, the level of the 5PTASN fraction in the RF85A was 0.70, 0.64, 0.58, and 0.76 of that in the RF8 cheese, respectively (Table 9). It was interesting to note that the overall highest level of this fraction was found after 120 and 180d in the RF858AB cheese (Table 9). This finding may suggest the influence of sequential changes in temperature on microbial autolysis at early stages of the aging process along with the overall time at which the cheese was aged at 8 ℃. After 180 aging days, the level of the 5PTASN that has accumulated in the RF cheeses was in the order: RF858AB > RF858AC = RF85B = RF85A = RF585AC = RF58B = RF58A > RF585AB = RF5 (Table 9). Similarly, after 180 aging days, the level of 5PTASN in the FF cheeses was in the order: FF8 > FF58A = FF58B = FF858AB > FF585AB > FF85B = FF858AC = FF585AC = FF5 (Table 8).

    The observed significant effects of time-at-temperature conditions on the accumulation of the 5PTASN were in agreement with the reported influence of small changes in aging temperature on the accumulation of L-glutamic acid in Cheddar cheese [36]. A correlation between flavor development and the accumulation of 5PTASN fraction during aging of Cheddar cheese has been established [7,31,33]. In light of the latter, the results of the present study clearly suggested that small changes in aging temperature within the range of 5 and 8℃ can potentially affect the development of flavor in both FF and RF Cheddar cheese.

    Results of the study have revealed differences between the extent to which the aging conditions affected the accumulation of the different cheese-N fractions in the FF and in the RF cheeses (Tables 4-9). The magnitude of such differences and their trend varied with aging time and were influenced by the aging conditions. After 60, 120, and 180 days of non-isothermal aging, the ratio of the pH 4.6SN fraction in the FF to that in the RF cheeses exhibited a mixed trend and was 0.89-1.19, 0.80-1.10, and 0.87-1.12, respectively (Tables 4 and 5). In most cases, the differences between the accumulation of the pH 4.6SN fraction in FF and RF cheeses were less than 20% and suggested the combined influence of the cheese composition and the time-at-temperature details of the aging on the accumulation of the pH 4.6SN fraction [9,41]. In all but 2 cases, the level of the 12TCASN fraction in the FF cheese was higher than that in the RF cheese (Tables 6 and 7). Throughout 180 days of isothermal aging, the ratio of the 12TCASN fraction in the FF cheese to that in the RF cheese was 0.95-1.44 and 0.99-1.117, for cheeses aged at 5 and 8 ℃, respectively. Results obtained during the non-isothermal aging indicated that the differences between the level of 12TCASN fraction that accumulated in the FF and the RF cheeses varied with the time-at-temperature details of the aging program. After 60, 120, and 180 days, the ratio of the 12TCASN fraction in the FF cheeses to that in the RF cheeses was, 1.06-1.21, 0.98-1.18, and 1.04-1.19, respectively. Results (Tables 8 and 9) indicated that throughout 180 days of isothermal aging, the ratio of the 5PTASN fraction in the FF cheese to that in the RF cheese was 1.33-1.62 and 0.93-1.23, for cheeses aged at 5 and 8 ℃, respectively. Results obtained during the non-isothermal aging indicated that in most cases the accumulation of the 5PTASN in the FF cheeses was to a higher level than that in the RF cheeses (Tables 8 and 9) and the differences between the level of 5PTASN fraction that accumulated in the FF and the RF cheeses varied with the time-at-temperature details of the aging program. After 60, 120, and 180 days, the ratio of the 5PTASN fraction in the FF cheeses to that in the RF cheeses was, 1.10-1.61, 0.88-1.60, and 0.97-1.41, respectively. Overall, the results of the study indicated that in most cases, the extent of proteolysis in the FF cheeses was higher than that in the RF, however, these differences were greatly affected by the time-at-temperature details of the aging program. The higher extent of proteolysis that was exhibited, in most cases, by the FF cheeses was similar to what has been previously reported and could be attributed to the effects of the lower protein-to-fat ratio in these cheeses [9,38,39,41]. It has been established that the latter had a major effect on the extent of proteolysis that could be attributed to the effects of lowering the fat content on the moisture-in-fat-free mass. This compositional change has been shown to affect the rate and extent of proteolysis during aging due to the impact on the evolution of pH during cheesemaking and aging, the retention of coagulant in the curd and the S/M in the cheese [9,38,39]

    Overall, results of the study have demonstrated that the proteolytic cascade that plays a major role in the aging of Cheddar cheese is significantly affected by the details of time-at-temperature during aging, even when the temperature changes by only 3 ℃. The results of the non-isothermal aging experiments have clearly demonstrated the potential for controlling not only the overall acceleration or deceleration of the proteolytic activities but also the time, during aging, at which the rate of the proteolytic cascade is modified. The significant among-aging-programs-differences in the accumulation of all the investigated cheese-N fraction represent opportunities for modulating the cheese ripening process, as needed. However, these same results also highlight the risks that are associated with aging cheese at conditions that allow the aging temperature to fluctuate, even slightly, during the aging and along the supply chain. The results thus highlight the need to tightly control the cheese aging temperature and suggest that falling short of meeting this goal is likely to lead to significant variations in the evolution of cheese quality attributes. Results (Tables 4-9) indicated that both primary proteolysis, that results in the accumulation of high- and medium-molecular-weight peptides, and the activity of microbial peptidases, that govern the accumulation of very small peptides and free amino acids, can be effectively modulated by small changes in aging temperature. The significant effect that temperature had on the accumulation of the different cheese-N fractions could be attributed to the effects of temperature on the rate of enzymatic reactions as well as on microbial autolysis and, probably, on the propagation of non-starter lactic acid bacteria during early stages of the aging process [4,6,30,42]. The ability to "tune" the progression of the proteolytic cascade has been suggested as an effective and inexpensive means for modulating the evolution of cheese quality attributes. Unlike most of the previous reports [6,30,31], the results of the present study clearly indicated that such opportunities can be exploited while maintaining the temperature lower than 10 ℃.

    The results of the study indicated that very small (3 ℃) changes in aging temperature had significant effects on the proteolytic cascade during aging of Cheddar cheese. The demonstrated capabilities to significantly modulate the evolution of proteolytic activities during aging at a temperature lower than 10 ℃ may open new potential opportunities for modulating the development of cheese quality attributes, such as texture and flavor, at conditions that are less likely to lead to the development of defects that are associated with aging at a temperature higher than 10 ℃. The results of the study offer a potential new approach for mitigating challenges that are associated with fluctuating market supply and demand as well as difficulties during disrupt supply chain. In light of the demonstrated significant effect of very small change in aging temperature on proteolysis during cheese aging, the results of the study highlight the critical importance of establishing and maintaining isotropic temperature distribution in cheese aging rooms. It has to be noted that although the significant effects of the investigated aging programs on the proteolytic cascade have been demonstrated, the impacts of these effects on the textural and sensorial characteristics of the cheese have yet to be investigated.

    No conflict of interest has been reported by the authors

    The authors express their gratitude to the California Dairy Research Foundation for providing a research fund to support this research.

    [1] Powers ET, Balch WE (2013) Diversity in the origins of proteostasis networks--a driver for protein function in evolution. Nat Rev Mol Cell Biol 14: 237-248. doi: 10.1038/nrm3542
    [2] Gidalevitz T, Prahlad V, Morimoto RI (2011) The stress of protein misfolding: from single cells to multicellular organisms. Cold Spring Harb Perspect Biol 3: a009704.
    [3] Balch WE, Morimoto RI, Dillin A, et al. (2008) Adapting proteostasis for disease intervention. Science 319: 916-919. doi: 10.1126/science.1141448
    [4] Powers ET, Morimoto RI, Dillin A, et al. (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78: 959-991. doi: 10.1146/annurev.biochem.052308.114844
    [5] López-Otín C, Blasco MA, Partridge L, et al. (2013) The Hallmarks of Aging. Cell 153: 1194-1217. doi: 10.1016/j.cell.2013.05.039
    [6] Kim YE, Hipp MS, Bracher A, et al. (2013) Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem 82: 323-355. doi: 10.1146/annurev-biochem-060208-092442
    [7] Haynes CM, Ron D (2010) The mitochondrial UPR - protecting organelle protein homeostasis. J Cell Sci 123: 3849-3855. doi: 10.1242/jcs.075119
    [8] Anckar J, Sistonen L (2011) Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu Rev Biochem 80: 1089-1115. doi: 10.1146/annurev-biochem-060809-095203
    [9] Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081-1086. doi: 10.1126/science.1209038
    [10] Tartaglia GG, Pechmann S, Dobson CM, et al. (2007) Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci 32: 204-206. doi: 10.1016/j.tibs.2007.03.005
    [11] Tartaglia GG, Dobson CM, Hartl FU, et al. (2010) Physicochemical determinants of chaperone requirements. J Mol Biol 400: 579-588. doi: 10.1016/j.jmb.2010.03.066
    [12] Gsponer J, Babu MM (2012) Cellular strategies for regulating functional and nonfunctional protein aggregation. Cell Rep 2: 1425-1437. doi: 10.1016/j.celrep.2012.09.036
    [13] Ciryam P, Kundra R, Morimoto RI, et al. (2015) Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases. Trends Pharmacol Sci 36: 72-77. doi: 10.1016/j.tips.2014.12.004
    [14] Ellis RJ, Hartl FU (1999) Principles of protein folding in the cellular environment. Curr Opin Struct Biol 9: 102-110. doi: 10.1016/S0959-440X(99)80013-X
    [15] Van den Berg B, Ellis RJ, Dobson CM (1999) Effects of macromolecular crowding on protein folding and aggregation. EMBO J 18: 6927-6933. doi: 10.1093/emboj/18.24.6927
    [16] Ellis RJ, Minton AP (2006) Protein aggregation in crowded environments. Biol Chem 387: 485-497.
    [17] Hartl FU, Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295: 1852-1858. doi: 10.1126/science.1068408
    [18] Onuchic JN, Wolynes PG (2004) Theory of protein folding. Curr Opin Struct Biol 14: 70-75. doi: 10.1016/j.sbi.2004.01.009
    [19] Oliveberg M, Wolynes PG (2005) The experimental survey of protein-folding energy landscapes. Q Rev Biophys 38: 245-288. doi: 10.1017/S0033583506004185
    [20] Brockwell DJ, Radford SE (2007) Intermediates: ubiquitous species on folding energy landscapes? Curr Opin Struct Biol 17: 30-37. doi: 10.1016/j.sbi.2007.01.003
    [21] Bartlett AI, Radford SE (2009) An expanding arsenal of experimental methods yields an explosion of insights into protein folding mechanisms. Nat Struct Mol Biol 16: 582-588. doi: 10.1038/nsmb.1592
    [22] Eichner T, Kalverda AP, Thompson GS, et al. (2011) Conformational conversion during amyloid formation at atomic resolution. Mol Cell 41: 161-172. doi: 10.1016/j.molcel.2010.11.028
    [23] Dobson CM (2003) Protein folding and misfolding. Nature 426: 884-890. doi: 10.1038/nature02261
    [24] Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat Rev Mol Cell Biol 8: 101-112.
    [25] Knowles TPJ, Vendruscolo M, Dobson CM (2014) The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 15: 384-396. doi: 10.1038/nrm3810
    [26] Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475: 324-332. doi: 10.1038/nature10317
    [27] Hartl FU (1996) Molecular chaperones in cellular protein folding. Nature 381: 571-579. doi: 10.1038/381571a0
    [28] Hartl FU, Hayer-Hartl M (2009) Converging concepts of protein folding in vitro and in vivo. Nat Struct Mol Biol 16: 574-581. doi: 10.1038/nsmb.1591
    [29] Moran L, Mirault ME, Arrigo AP, et al. (1978) Heat shock of Drosophila melanogaster induces the synthesis of new messenger RNAs and proteins. Philos Trans R Soc Lond B Biol Sci 283: 391-406. doi: 10.1098/rstb.1978.0044
    [30] Kayed R, Head E, Thompson JL, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489. doi: 10.1126/science.1079469
    [31] Slepenkov SV, Witt SN (2002) The unfolding story of the Escherichia coli Hsp70 DnaK: is DnaK a holdase or an unfoldase? Mol Microbiol 45: 1197-1206. doi: 10.1046/j.1365-2958.2002.03093.x
    [32] Bösl B, Grimminger V, Walter S (2006) The molecular chaperone Hsp104--a molecular machine for protein disaggregation. J Struct Biol 156: 139-148. doi: 10.1016/j.jsb.2006.02.004
    [33] Auluck PK, Chan HYE, Trojanowski JQ, et al. (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295: 865-868. doi: 10.1126/science.1067389
    [34] Gribaldo S, Lumia V, Creti R, et al. (1999) Discontinuous occurrence of the hsp70 (dnaK) gene among Archaea and sequence features of HSP70 suggest a novel outlook on phylogenies inferred from this protein. J Bacteriol 181: 434-443.
    [35] Chang H-C, Tang Y-C, Hayer-Hartl M, et al. (2007) SnapShot: Molecular Chaperones, Part I. Cell 128: 212.e1-e212.e2.
    [36] Macario AJL, Lange M, Ahring BK, et al. (1999) Stress Genes and Proteins in the Archaea. Microbiol Mol Biol Rev 63: 923-967.
    [37] Bukau B, Deuerling E, Pfund C, et al. (2000) Getting newly synthesized proteins into shape. Cell 101: 119-122. doi: 10.1016/S0092-8674(00)80806-5
    [38] Young JC, Barral JM, Ulrich Hartl F (2003) More than folding: localized functions of cytosolic chaperones. Trends Biochem Sci 28: 541-547. doi: 10.1016/j.tibs.2003.08.009
    [39] Pratt WB, Toft DO (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med Maywood NJ 228: 111-133.
    [40] Mayer MP, Bukau B (2005) Hsp70 chaperones: Cellular functions and molecular mechanism. Cell Mol Life Sci 62: 670-684. doi: 10.1007/s00018-004-4464-6
    [41] Mayer MP (2010) Gymnastics of Molecular Chaperones. Mol Cell 39: 321-331. doi: 10.1016/j.molcel.2010.07.012
    [42] Kampinga HH, Craig EA (2010) The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 11: 579-592. doi: 10.1038/nrm2941
    [43] Arndt V, Dick N, Tawo R, et al. (2010) Chaperone-Assisted Selective Autophagy Is Essential for Muscle Maintenance. Curr Biol 20: 143-148. doi: 10.1016/j.cub.2009.11.022
    [44] Rüdiger S, Buchberger A, Bukau B (1997) Interaction of Hsp70 chaperones with substrates. Nat Struct Mol Biol 4: 342-349. doi: 10.1038/nsb0597-342
    [45] Rousseau F, Serrano L, Schymkowitz JWH (2006) How evolutionary pressure against protein aggregation shaped chaperone specificity. J Mol Biol 355: 1037-1047. doi: 10.1016/j.jmb.2005.11.035
    [46] Frydman J (2001) Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu Rev Biochem 70: 603-647. doi: 10.1146/annurev.biochem.70.1.603
    [47] McClellan AJ, Xia Y, Deutschbauer AM, et al. (2007) Diverse Cellular Functions of the Hsp90 Molecular Chaperone Uncovered Using Systems Approaches. Cell 131: 121-135. doi: 10.1016/j.cell.2007.07.036
    [48] Taipale M, Jarosz DF, Lindquist S (2010) HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11: 515-528. doi: 10.1038/nrm2918
    [49] Bukau B, Horwich AL (1998) The Hsp70 and Hsp60 chaperone machines. Cell 92: 351-366. doi: 10.1016/S0092-8674(00)80928-9
    [50] Vabulas RM, Raychaudhuri S, Hayer-Hartl M, et al. (2010) Protein folding in the cytoplasm and the heat shock response. Cold Spring Harb Perspect Biol 2: a004390.
    [51] Raineri E, Ribeca P, Serrano L, et al. (2010) A more precise characterization of chaperonin substrates. Bioinforma Oxf Engl 26: 1685-1689. doi: 10.1093/bioinformatics/btq287
    [52] Xu Z, Horwich AL, Sigler PB (1997) The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature 388: 741-750. doi: 10.1038/41944
    [53] Horwich AL, Fenton WA (2009) Chaperonin-mediated protein folding: using a central cavity to kinetically assist polypeptide chain folding. Q Rev Biophys 42: 83-116. doi: 10.1017/S0033583509004764
    [54] Motojima F, Chaudhry C, Fenton WA, et al. (2004) Substrate polypeptide presents a load on the apical domains of the chaperonin GroEL. Proc Natl Acad Sci U S A 101: 15005-15012. doi: 10.1073/pnas.0406132101
    [55] Reissmann S, Parnot C, Booth CR, et al. (2007) Essential function of the built-in lid in the allosteric regulation of eukaryotic and archaeal chaperonins. Nat Struct Mol Biol 14: 432-440. doi: 10.1038/nsmb1236
    [56] Muñoz IG, Yébenes H, Zhou M, et al. (2011) Crystal structure of the open conformation of the mammalian chaperonin CCT in complex with tubulin. Nat Struct Mol Biol 18: 14-19. doi: 10.1038/nsmb.1971
    [57] Cuéllar J, Martín-Benito J, Scheres SHW, et al. (2008) The structure of CCT-Hsc70 NBD suggests a mechanism for Hsp70 delivery of substrates to the chaperonin. Nat Struct Mol Biol 15: 858-864. doi: 10.1038/nsmb.1464
    [58] Lai BT, Chin NW, Stanek AE, et al. (1984) Quantitation and intracellular localization of the 85K heat shock protein by using monoclonal and polyclonal antibodies. Mol Cell Biol 4: 2802-2810.
    [59] Ali MMU, Roe SM, Vaughan CK, et al. (2006) Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 440: 1013-1017. doi: 10.1038/nature04716
    [60] Shiau AK, Harris SF, Southworth DR, et al. (2006) Structural Analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell 127: 329-340.
    [61] Wandinger SK, Richter K, Buchner J (2008) The Hsp90 Chaperone Machinery. J Biol Chem 283: 18473-18477. doi: 10.1074/jbc.R800007200
    [62] Rutherford SL, Lindquist S (1998) Hsp90 as a capacitor for morphological evolution. Nature 396: 336-342. doi: 10.1038/24550
    [63] Squires CL, Pedersen S, Ross BM, et al. (1991) ClpB is the Escherichia coli heat shock protein F84.1. J Bacteriol 173: 4254-4262.
    [64] Parsell DA, Kowal AS, Singer MA, et al. (1994) Protein disaggregation mediated by heat-shock protein Hsp104. Nature 372: 475-478. doi: 10.1038/372475a0
    [65] Lee YR, Nagao RT, Key JL (1994) A soybean 101-kD heat shock protein complements a yeast HSP104 deletion mutant in acquiring thermotolerance. Plant Cell Online 6: 1889-1897. doi: 10.1105/tpc.6.12.1889
    [66] Chernoff YO, Lindquist SL, Ono B, et al. (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268: 880-884. doi: 10.1126/science.7754373
    [67] Schirmer EC, Glover JR, Singer MA, et al. (1996) HSP100/Clp proteins: a common mechanism explains diverse functions. Trends Biochem Sci 21: 289-296. doi: 10.1016/S0968-0004(96)10038-4
    [68] Zolkiewski M (2006) A camel passes through the eye of a needle: protein unfolding activity of Clp ATPases. Mol Microbiol 61: 1094-1100. doi: 10.1111/j.1365-2958.2006.05309.x
    [69] Erzberger JP, Berger JM (2006) Evolutionary relationships and structural mechanisms of AAA+ proteins. Annu Rev Biophys Biomol Struct 35: 93-114. doi: 10.1146/annurev.biophys.35.040405.101933
    [70] Zietkiewicz S, Lewandowska A, Stocki P, et al. (2006) Hsp70 chaperone machine remodels protein aggregates at the initial step of Hsp70-Hsp100-dependent disaggregation. J Biol Chem 281: 7022-7029. doi: 10.1074/jbc.M507893200
    [71] Miot M, Reidy M, Doyle SM, et al. (2011) Species-specific collaboration of heat shock proteins (Hsp) 70 and 100 in thermotolerance and protein disaggregation. Proc Natl Acad Sci U S A 108: 6915-6920. doi: 10.1073/pnas.1102828108
    [72] Reidy M, Miot M, Masison DC (2012) Prokaryotic chaperones support yeast prions and thermotolerance and define disaggregation machinery interactions. Genetics 192: 185-193. doi: 10.1534/genetics.112.142307
    [73] Seyffer F, Kummer E, Oguchi Y, et al. (2012) Hsp70 proteins bind Hsp100 regulatory M domains to activate AAA+ disaggregase at aggregate surfaces. Nat Struct Mol Biol 19: 1347-1355. doi: 10.1038/nsmb.2442
    [74] Sanchez Y, Taulien J, Borkovich KA, et al. (1992) Hsp104 is required for tolerance to many forms of stress. EMBO J 11: 2357-2364.
    [75] Parsell DA, Lindquist S (1993) The Function of Heat-Shock Proteins in Stress Tolerance: Degradation and Reactivation of Damaged Proteins. Annu Rev Genet 27: 437-496. doi: 10.1146/annurev.ge.27.120193.002253
    [76] Weibezahn J, Tessarz P, Schlieker C, et al. (2004) Thermotolerance requires refolding of aggregated proteins by substrate translocation through the central pore of ClpB. Cell 119: 653-665. doi: 10.1016/j.cell.2004.11.027
    [77] Rampelt H, Kirstein-Miles J, Nillegoda NB, et al. (2012) Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. EMBO J 31: 4221-4235. doi: 10.1038/emboj.2012.264
    [78] Schuermann JP, Jiang J, Cuellar J, et al. (2008) Structure of the Hsp110:Hsc70 nucleotide exchange machine. Mol Cell 31: 232-243. doi: 10.1016/j.molcel.2008.05.006
    [79] Shorter J (2011) The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PloS One 6: e26319. doi: 10.1371/journal.pone.0026319
    [80] Morano KA, Thiele DJ (1999) Heat shock factor function and regulation in response to cellular stress, growth, and differentiation signals. Gene Expr 7: 271-282.
    [81] Anckar J, Sistonen L (2007) Heat shock factor 1 as a coordinator of stress and developmental pathways. Adv Exp Med Biol 594: 78-88. doi: 10.1007/978-0-387-39975-1_8
    [82] Abravaya K, Phillips B, Morimoto RI (1991) Attenuation of the heat shock response in HeLa cells is mediated by the release of bound heat shock transcription factor and is modulated by changes in growth and in heat shock temperatures. Genes Dev 5: 2117-2127. doi: 10.1101/gad.5.11.2117
    [83] Morley JF, Morimoto RI (2004) Regulation of Longevity in Caenorhabditis elegans by Heat Shock Factor and Molecular Chaperones. Mol Biol Cell 15: 657-664.
    [84] Lindquist SL, Kelly JW (2011) Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis. Cold Spring Harb Perspect Biol 3: a004507
    [85] Akerfelt M, Trouillet D, Mezger V, et al. (2007) Heat shock factors at a crossroad between stress and development. Ann N Y Acad Sci 1113: 15-27. doi: 10.1196/annals.1391.005
    [86] Ostling P, Björk JK, Roos-Mattjus P, et al. (2007) Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1. J Biol Chem 282: 7077-7086.
    [87] Shinkawa T, Tan K, Fujimoto M, et al. (2011) Heat shock factor 2 is required for maintaining proteostasis against febrile-range thermal stress and polyglutamine aggregation. Mol Biol Cell 22: 3571-3583. doi: 10.1091/mbc.E11-04-0330
    [88] Xie J, Tang L, Lu L, et al. (2014) Differential expression of heat shock transcription factors and heat shock proteins after acute and chronic heat stress in laying chickens (Gallus gallus). PloS One 9: e102204. doi: 10.1371/journal.pone.0102204
    [89] Shi Y, Mosser DD, Morimoto RI (1998) Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev 12: 654-666. doi: 10.1101/gad.12.5.654
    [90] Zou J, Guo Y, Guettouche T, et al. (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94: 471-480. doi: 10.1016/S0092-8674(00)81588-3
    [91] Morimoto RI (1998) Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 12: 3788-3796. doi: 10.1101/gad.12.24.3788
    [92] Vujanac M, Fenaroli A, Zimarino V (2005) Constitutive nuclear import and stress-regulated nucleocytoplasmic shuttling of mammalian heat-shock factor 1. Traffic Cph Den 6: 214-229. doi: 10.1111/j.1600-0854.2005.00266.x
    [93] Whitesell L, Lindquist S (2009) Inhibiting the transcription factor HSF1 as an anticancer strategy. Expert Opin Ther Targets 13: 469-478. doi: 10.1517/14728220902832697
    [94] Lis J, Wu C (1993) Protein traffic on the heat shock promoter: parking, stalling, and trucking along. Cell 74: 1-4. doi: 10.1016/0092-8674(93)90286-Y
    [95] Hong Y, Rogers R, Matunis MJ, et al. (2001) Regulation of Heat Shock Transcription Factor 1 by Stress-induced SUMO-1 Modification. J Biol Chem 276: 40263-40267. doi: 10.1074/jbc.M104714200
    [96] Guettouche T, Boellmann F, Lane WS, et al. (2005) Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem 6: 4. doi: 10.1186/1471-2091-6-4
    [97] Shamovsky I, Nudler E (2008) New insights into the mechanism of heat shock response activation. Cell Mol Life Sci CMLS 65: 855-861. doi: 10.1007/s00018-008-7458-y
    [98] Westerheide SD, Anckar J, Stevens SM, et al. (2009) Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323: 1063-1066. doi: 10.1126/science.1165946
    [99] Gómez AV, Galleguillos D, Maass JC, et al. (2008) CoREST represses the heat shock response mediated by HSF1. Mol Cell 31: 222-231. doi: 10.1016/j.molcel.2008.06.015
    [100] Xu D, Zalmas LP, La Thangue NB (2008) A transcription cofactor required for the heat-shock response. EMBO Rep 9: 662-669. doi: 10.1038/embor.2008.70
    [101] Baler R, Welch WJ, Voellmy R (1992) Heat shock gene regulation by nascent polypeptides and denatured proteins: hsp70 as a potential autoregulatory factor. J Cell Biol 117: 1151-1159. doi: 10.1083/jcb.117.6.1151
    [102] Powers MV, Workman P (2007) Inhibitors of the heat shock response: Biology and pharmacology. FEBS Lett 581: 3758-3769. doi: 10.1016/j.febslet.2007.05.040
    [103] Van Oosten-Hawle P, Morimoto RI (2014) Transcellular chaperone signaling: an organismal strategy for integrated cell stress responses. J Exp Biol 217: 129-136. doi: 10.1242/jeb.091249
    [104] Feder JH, Rossi JM, Solomon J, et al. (1992) The consequences of expressing hsp70 in Drosophila cells at normal temperatures. Genes Dev 6: 1402-1413. doi: 10.1101/gad.6.8.1402
    [105] Braakman I, Bulleid NJ (2011) Protein folding and modification in the mammalian endoplasmic reticulum. Annu Rev Biochem 80: 71-99. doi: 10.1146/annurev-biochem-062209-093836
    [106] Wang S, Kaufman RJ (2012) The impact of the unfolded protein response on human disease. J Cell Biol 197: 857-867. doi: 10.1083/jcb.201110131
    [107] Cox JS, Shamu CE, Walter P (1993) Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 73: 1197-1206. doi: 10.1016/0092-8674(93)90648-A
    [108] Mori K, Ma W, Gething MJ, et al. (1993) A transmembrane protein with a cdc2+/CDC28-related kinase activity is required for signaling from the ER to the nucleus. Cell 74: 743-756. doi: 10.1016/0092-8674(93)90521-Q
    [109] Shamu CE, Walter P (1996) Oligomerization and phosphorylation of the Ire1p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus. EMBO J 15: 3028-3039.
    [110] Yoshida H, Matsui T, Yamamoto A, et al. (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881-891. doi: 10.1016/S0092-8674(01)00611-0
    [111] Calfon M, Zeng H, Urano F, et al. (2002) IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415: 92-96. doi: 10.1038/415092a
    [112] Hetz C, Martinon F, Rodriguez D, et al. (2011) The unfolded protein response: integrating stress signals through the stress sensor IRE1α. Physiol Rev 91: 1219-1243. doi: 10.1152/physrev.00001.2011
    [113] Urano F, Wang X, Bertolotti A, et al. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664-666. doi: 10.1126/science.287.5453.664
    [114] Yoneda T, Imaizumi K, Oono K, et al. (2001) Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem 276: 13935-13940.
    [115] Nishitoh H, Matsuzawa A, Tobiume K, et al. (2002) ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16: 1345-1355. doi: 10.1101/gad.992302
    [116] Hetz C, Bernasconi P, Fisher J, et al. (2006) Proapoptotic BAX and BAK Modulate the Unfolded Protein Response by a Direct Interaction with IRE1α. Science 312: 572-576. doi: 10.1126/science.1123480
    [117] Shi Y, Vattem KM, Sood R, et al. (1998) Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol Cell Biol 18: 7499-7509.
    [118] Harding HP, Zhang Y, Bertolotti A, et al. (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 5: 897-904. doi: 10.1016/S1097-2765(00)80330-5
    [119] Scheuner D, Song B, McEwen E, et al. (2001) Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 7: 1165-1176. doi: 10.1016/S1097-2765(01)00265-9
    [120] Harding HP, Novoa I, Zhang Y, et al. (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6: 1099-1108. doi: 10.1016/S1097-2765(00)00108-8
    [121] Harding HP, Zhang Y, Zeng H, et al. (2003) An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress. Mol Cell 11: 619-633. doi: 10.1016/S1097-2765(03)00105-9
    [122] Ameri K, Harris AL (2008) Activating transcription factor 4. Int J Biochem Cell Biol 40: 14-21. doi: 10.1016/j.biocel.2007.01.020
    [123] Connor JH, Weiser DC, Li S, et al. (2001) Growth Arrest and DNA Damage-Inducible Protein GADD34 Assembles a Novel Signaling Complex Containing Protein Phosphatase 1 and Inhibitor 1. Mol Cell Biol 21: 6841-6850. doi: 10.1128/MCB.21.20.6841-6850.2001
    [124] Novoa I, Zeng H, Harding HP, et al. (2001) Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α. J Cell Biol 153: 1011-1022. doi: 10.1083/jcb.153.5.1011
    [125] Ma Y, Hendershot LM (2003) Delineation of a negative feedback regulatory loop that controls protein translation during endoplasmic reticulum stress. J Biol Chem 278: 34864-34873. doi: 10.1074/jbc.M301107200
    [126] Cullinan SB, Zhang D, Hannink M, et al. (2003) Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival. Mol Cell Biol 23: 7198-7209. doi: 10.1128/MCB.23.20.7198-7209.2003
    [127] Ye J, Rawson RB, Komuro R, et al. (2000) ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 6: 1355-1364. doi: 10.1016/S1097-2765(00)00133-7
    [128] Okada T, Yoshida H, Akazawa R, et al. (2002) Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response. Biochem J 366: 585-594. doi: 10.1042/BJ20020391
    [129] Adachi Y, Yamamoto K, Okada T, et al. (2008) ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum. Cell Struct Funct 33: 75-89. doi: 10.1247/csf.07044
    [130] Tirosh B, Iwakoshi NN, Glimcher LH, et al. (2006) Rapid Turnover of Unspliced Xbp-1 as a Factor That Modulates the Unfolded Protein Response. J Biol Chem 281: 5852-5860.
    [131] Yoshida H, Oku M, Suzuki M, et al. (2006) pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J Cell Biol 172: 565-575. doi: 10.1083/jcb.200508145
    [132] Yoshida H, Uemura A, Mori K (2009) pXBP1(U), a negative regulator of the unfolded protein response activator pXBP1(S), targets ATF6 but not ATF4 in proteasome-mediated degradation. Cell Struct Funct 34: 1-10. doi: 10.1247/csf.06028
    [133] Oyadomari S, Yun C, Fisher EA, et al. (2006) Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload. Cell 126: 727-739. doi: 10.1016/j.cell.2006.06.051
    [134] Yamamoto K, Sato T, Matsui T, et al. (2007) Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Dev Cell 13: 365-376. doi: 10.1016/j.devcel.2007.07.018
    [135] Zhao Q, Wang J, Levichkin IV, et al. (2002) A mitochondrial specific stress response in mammalian cells. EMBO J 21: 4411-4419. doi: 10.1093/emboj/cdf445
    [136] Benedetti C, Haynes CM, Yang Y, et al. (2006) Ubiquitin-Like Protein 5 Positively Regulates Chaperone Gene Expression in the Mitochondrial Unfolded Protein Response. Genetics 174: 229-239. doi: 10.1534/genetics.106.061580
    [137] Aldridge JE, Horibe T, Hoogenraad NJ (2007) Discovery of Genes Activated by the Mitochondrial Unfolded Protein Response (mtUPR) and Cognate Promoter Elements. PLoS ONE 2: e874
    [138] Haynes CM, Petrova K, Benedetti C, et al. (2007) ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev Cell 13: 467-480. doi: 10.1016/j.devcel.2007.07.016
    [139] Horibe T, Hoogenraad NJ (2007) The Chop Gene Contains an Element for the Positive Regulation of the Mitochondrial Unfolded Protein Response. PLoS ONE 2: e835
    [140] Haynes CM, Yang Y, Blais SP, et al. (2010) The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol Cell 37: 529-540.
    [141] Nargund AM, Pellegrino MW, Fiorese CJ, et al. (2012) Mitochondrial Import Efficiency of ATFS-1 Regulates Mitochondrial UPR Activation. Science 337: 587-590. doi: 10.1126/science.1223560
    [142] Baker BM, Nargund AM, Sun T, et al. (2012) Protective coupling of mitochondrial function and protein synthesis via the eIF2α kinase GCN-2. PLoS Genet 8: e1002760. doi: 10.1371/journal.pgen.1002760
    [143] Runkel ED, Liu S, Baumeister R, et al. (2013) Surveillance-activated defenses block the ROS-induced mitochondrial unfolded protein response. PLoS Genet 9: e1003346. doi: 10.1371/journal.pgen.1003346
    [144] Jovaisaite V, Mouchiroud L, Auwerx J (2014) The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease. J Exp Biol 217: 137-143. doi: 10.1242/jeb.090738
    [145] Shibata Y, Morimoto RI (2014) How the nucleus copes with proteotoxic stress. Curr Biol 24: R463-R474. doi: 10.1016/j.cub.2014.03.033
    [146] Fried H, Kutay U (2003) Nucleocytoplasmic transport: taking an inventory. Cell Mol Life Sci 60: 1659-1688. doi: 10.1007/s00018-003-3070-3
    [147] Melchior F, Gerace L (1995) Mechanisms of nuclear protein import. Curr Opin Cell Biol 7: 310-318. doi: 10.1016/0955-0674(95)80084-0
    [148] Longshaw VM, Chapple JP, Balda MS, et al. (2004) Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases. J Cell Sci 117: 701-710. doi: 10.1242/jcs.00905
    [149] Dezwaan DC, Freeman BC (2008) HSP90: the Rosetta stone for cellular protein dynamics? Cell Cycle Georget Tex 7: 1006-1012. doi: 10.4161/cc.7.8.5723
    [150] Furuta M, Kose S, Koike M, et al. (2004) Heat-shock induced nuclear retention and recycling inhibition of importin alpha. Genes Cells Devoted Mol Cell Mech 9: 429-441. doi: 10.1111/j.1356-9597.2004.00734.x
    [151] Miyamoto Y, Saiwaki T, Yamashita J, et al. (2004) Cellular stresses induce the nuclear accumulation of importin alpha and cause a conventional nuclear import block. J Cell Biol 165: 617-623. doi: 10.1083/jcb.200312008
    [152] Kose S, Furuta M, Imamoto N (2012) Hikeshi, a nuclear import carrier for Hsp70s, protects cells from heat shock-induced nuclear damage. Cell 149: 578-589. doi: 10.1016/j.cell.2012.02.058
    [153] DiFiglia M, Sapp E, Chase KO, et al. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277: 1990-1993. doi: 10.1126/science.277.5334.1990
    [154] Paulson HL, Perez MK, Trottier Y, et al. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19: 333-344. doi: 10.1016/S0896-6273(00)80943-5
    [155] Udan-Johns M, Bengoechea R, Bell S, et al. (2014) Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum Mol Genet 23: 157-170. doi: 10.1093/hmg/ddt408
    [156] Kim S, Nollen EAA, Kitagawa K, et al. (2002) Polyglutamine protein aggregates are dynamic. Nat Cell Biol 4: 826-831. doi: 10.1038/ncb863
    [157] Lee DH, Goldberg AL (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 8: 397-403. doi: 10.1016/S0962-8924(98)01346-4
    [158] Deshaies RJ, Joazeiro CAP (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399-434. doi: 10.1146/annurev.biochem.78.101807.093809
    [159] Ristic G, Tsou W-L, Todi SV (2014) An optimal ubiquitin-proteasome pathway in the nervous system: the role of deubiquitinating enzymes. Front Mol Neurosci 7: 72.
    [160] Bhattacharyya S, Yu H, Mim C, et al. (2014) Regulated protein turnover: snapshots of the proteasome in action. Nat Rev Mol Cell Biol 15: 122-133. doi: 10.1038/nrm3741
    [161] Bedford L, Paine S, Sheppard PW, et al. (2010) Assembly, structure, and function of the 26S proteasome. Trends Cell Biol 20: 391-401. doi: 10.1016/j.tcb.2010.03.007
    [162] Clark PL (2004) Protein folding in the cell: reshaping the folding funnel. Trends Biochem Sci 29: 527-534. doi: 10.1016/j.tibs.2004.08.008
    [163] Kloetzel PM, Ossendorp F (2004) Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 16: 76-81. doi: 10.1016/j.coi.2003.11.004
    [164] Kriegenburg F, Ellgaard L, Hartmann-Petersen R (2012) Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation. FEBS J 279: 532-542. doi: 10.1111/j.1742-4658.2011.08456.x
    [165] Von Mikecz A (2006) The nuclear ubiquitin-proteasome system. J Cell Sci 119: 1977-1984. doi: 10.1242/jcs.03008
    [166] Bader N, Jung T, Grune T (2007) The proteasome and its role in nuclear protein maintenance. Exp Gerontol 42: 864-870. doi: 10.1016/j.exger.2007.03.010
    [167] Ullrich O, Reinheckel T, Sitte N, et al. (1999) Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci U S A 96: 6223-6228. doi: 10.1073/pnas.96.11.6223
    [168] Andersen JS, Lam YW, Leung AKL, et al. (2005) Nucleolar proteome dynamics. Nature 433: 77-83. doi: 10.1038/nature03207
    [169] Janer A, Martin E, Muriel M-P, et al. (2006) PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. J Cell Biol 174: 65-76. doi: 10.1083/jcb.200511045
    [170] Lam YW, Lamond AI, Mann M, et al. (2007) Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol 17: 749-760. doi: 10.1016/j.cub.2007.03.064
    [171] Iwata A, Nagashima Y, Matsumoto L, et al. (2009) Intranuclear Degradation of Polyglutamine Aggregates by the Ubiquitin-Proteasome System. J Biol Chem 284: 9796-9803. doi: 10.1074/jbc.M809739200
    [172] Catic A, Suh CY, Hill CT, et al. (2013) Genome-wide map of nuclear protein degradation shows NCoR1 turnover as a key to mitochondrial gene regulation. Cell 155: 1380-1395. doi: 10.1016/j.cell.2013.11.016
    [173] Komander D, Rape M (2012) The Ubiquitin Code. Annu Rev Biochem 81: 203-229. doi: 10.1146/annurev-biochem-060310-170328
    [174] Kraft C, Peter M, Hofmann K (2010) Selective autophagy: ubiquitin-mediated recognition and beyond. Nat Cell Biol 12: 836-841. doi: 10.1038/ncb0910-836
    [175] Nathan JA, Kim HT, Ting L, et al. (2013) Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? EMBO J 32: 552-565. doi: 10.1038/emboj.2012.354
    [176] Wang F, Durfee LA, Huibregtse JM (2013) A cotranslational ubiquitination pathway for quality control of misfolded proteins. Mol Cell 50: 368-378. doi: 10.1016/j.molcel.2013.03.009
    [177] Seet BT, Dikic I, Zhou M-M, et al. (2006) Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 7: 473-483. doi: 10.1038/nrm1960
    [178] Sekijima Y, Wiseman RL, Matteson J, et al. (2005) The biological and chemical basis for tissue-selective amyloid disease. Cell 121: 73-85. doi: 10.1016/j.cell.2005.01.018
    [179] Taxis C, Hitt R, Park S-H, et al. (2003) Use of modular substrates demonstrates mechanistic diversity and reveals differences in chaperone requirement of ERAD. J Biol Chem 278: 35903-35913. doi: 10.1074/jbc.M301080200
    [180] Vashist S, Ng DTW (2004) Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J Cell Biol 165: 41-52. doi: 10.1083/jcb.200309132
    [181] Carvalho P, Goder V, Rapoport TA (2006) Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell 126: 361-373. doi: 10.1016/j.cell.2006.05.043
    [182] Araki K, Nagata K (2011) Protein folding and quality control in the ER. Cold Spring Harb Perspect Biol 3: a007526.
    [183] Chapman E, Fry AN, Kang M (2011) The complexities of p97 function in health and disease. Mol Biosyst 7: 700-710. doi: 10.1039/C0MB00176G
    [184] Medicherla B, Kostova Z, Schaefer A, et al. (2004) A genomic screen identifies Dsk2p and Rad23p as essential components of ER-associated degradation. EMBO Rep 5: 692-697. doi: 10.1038/sj.embor.7400164
    [185] Claessen JHL, Ploegh HL (2011) BAT3 guides misfolded glycoproteins out of the endoplasmic reticulum. PloS One 6: e28542. doi: 10.1371/journal.pone.0028542
    [186] Xu Y, Cai M, Yang Y, et al. (2012) SGTA recognizes a noncanonical ubiquitin-like domain in the Bag6-Ubl4A-Trc35 complex to promote endoplasmic reticulum-associated degradation. Cell Rep 2: 1633-1644. doi: 10.1016/j.celrep.2012.11.010
    [187] Codogno P, Meijer AJ (2005) Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 12 Suppl 2: 1509-1518.
    [188] Cuervo AM, Wong ESP, Martinez-Vicente M (2010) Protein degradation, aggregation, and misfolding. Mov Disord Off J Mov Disord Soc 25 Suppl 1: S49-S54.
    [189] Ciechanover A, Kwon YT (2015) Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 47: e147. doi: 10.1038/emm.2014.117
    [190] Nixon RA (2013) The role of autophagy in neurodegenerative disease. Nat Med 19: 983-997. doi: 10.1038/nm.3232
    [191] Kiffin R, Christian C, Knecht E, et al. (2004) Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 15: 4829-4840. doi: 10.1091/mbc.E04-06-0477
    [192] Wang G, Mao Z (2014) Chaperone-mediated autophagy: roles in neurodegeneration. Transl Neurodegener 3: 20. doi: 10.1186/2047-9158-3-20
    [193] Eskelinen E-L, Illert AL, Tanaka Y, et al. (2002) Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell 13: 3355-3368. doi: 10.1091/mbc.E02-02-0114
    [194] Saftig P, Klumperman J (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 10: 623-635.
    [195] Hara T, Nakamura K, Matsui M, et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885-889. doi: 10.1038/nature04724
    [196] Komatsu M, Waguri S, Chiba T, et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-884. doi: 10.1038/nature04723
    [197] Oosten-Hawle P van, Morimoto RI (2014) Organismal proteostasis: role of cell-nonautonomous regulation and transcellular chaperone signaling. Genes Dev 28: 1533-1543. doi: 10.1101/gad.241125.114
    [198] Garcia SM, Casanueva MO, Silva MC, et al. (2007) Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells. Genes Dev 21: 3006-3016. doi: 10.1101/gad.1575307
    [199] Prahlad V, Cornelius T, Morimoto RI (2008) Regulation of the cellular heat shock response in Caenorhabditis elegans by thermosensory neurons. Science 320: 811-814. doi: 10.1126/science.1156093
    [200] Mori I, Sasakura H, Kuhara A (2007) Worm thermotaxis: a model system for analyzing thermosensation and neural plasticity. Curr Opin Neurobiol 17: 712-719. doi: 10.1016/j.conb.2007.11.010
    [201] Prahlad V, Morimoto RI (2011) Neuronal circuitry regulates the response of Caenorhabditis elegans to misfolded proteins. Proc Natl Acad Sci U S A 108: 14204-14209. doi: 10.1073/pnas.1106557108
    [202] Sugi T, Nishida Y, Mori I (2011) Regulation of behavioral plasticity by systemic temperature signaling in Caenorhabditis elegans. Nat Neurosci 14: 984-992. doi: 10.1038/nn.2854
    [203] Fawcett TW, Sylvester SL, Sarge KD, et al. (1994) Effects of neurohormonal stress and aging on the activation of mammalian heat shock factor 1. J Biol Chem 269: 32272-32278.
    [204] Maman M, Carvalhal Marques F, Volovik Y, et al. (2013) A neuronal GPCR is critical for the induction of the heat shock response in the nematode C. elegans. J Neurosci Off J Soc Neurosci 33: 6102-6111. doi: 10.1523/JNEUROSCI.4023-12.2013
    [205] Tatum MC, Ooi FK, Chikka MR, et al. (2015) Neuronal Serotonin Release Triggers the Heat Shock Response in C. elegans in the Absence of Temperature Increase. Curr Biol 25: 163-174.
    [206] Styer KL, Singh V, Macosko E, et al. (2008) Innate immunity in Caenorhabditis elegans is regulated by neurons expressing NPR-1/GPCR. Science 322: 460-464. doi: 10.1126/science.1163673
    [207] Sun J, Singh V, Kajino-Sakamoto R, et al. (2011) Neuronal GPCR Controls Innate Immunity by Regulating Non-Canonical Unfolded Protein Response Genes. Science 332: 729-732. doi: 10.1126/science.1203411
    [208] Zhang Y, Lu H, Bargmann CI (2005) Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans. Nature 438: 179-184. doi: 10.1038/nature04216
    [209] Pradel E, Zhang Y, Pujol N, et al. (2007) Detection and avoidance of a natural product from the pathogenic bacterium Serratia marcescens by Caenorhabditis elegans. Proc Natl Acad Sci U S A 104: 2295-2300. doi: 10.1073/pnas.0610281104
    [210] Anyanful A, Easley KA, Benian GM, et al. (2009) Conditioning protects C. elegans from lethal effects of enteropathogenic E. coli through activation of genes that regulate lifespan and innate immunity. Cell Host Microbe 5: 450-462.
    [211] Sun J, Liu Y, Aballay A (2012) Organismal regulation of XBP-1-mediated unfolded protein response during development and immune activation. EMBO Rep 13: 855-860. doi: 10.1038/embor.2012.100
    [212] Taylor RC, Dillin A (2013) XBP-1 is a cell-nonautonomous regulator of stress resistance and longevity. Cell 153: 1435-1447. doi: 10.1016/j.cell.2013.05.042
    [213] Kozlowski L, Garvis S, Bedet C, et al. (2014) The Caenorhabditis elegans HP1 family protein HPL-2 maintains ER homeostasis through the UPR and hormesis. Proc Natl Acad Sci U S A 111: 5956-5961. doi: 10.1073/pnas.1321698111
    [214] Durieux J, Wolff S, Dillin A (2011) The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144: 79-91. doi: 10.1016/j.cell.2010.12.016
    [215] Mizzen LA, Chang C, Garrels JI, et al. (1989) Identification, characterization, and purification of two mammalian stress proteins present in mitochondria, grp 75, a member of the hsp 70 family and hsp 58, a homolog of the bacterial groEL protein. J Biol Chem 264: 20664-20675.
    [216] Wanrooij S, Falkenberg M (2010) The human mitochondrial replication fork in health and disease. Biochim Biophys Acta 1797: 1378-1388. doi: 10.1016/j.bbabio.2010.04.015
    [217] Tan K, Fujimoto M, Takii R, et al. (2015) Mitochondrial SSBP1 protects cells from proteotoxic stresses by potentiating stress-induced HSF1 transcriptional activity. Nat Commun 6: 6580. doi: 10.1038/ncomms7580
    [218] Van Oosten-Hawle P, Porter RS, Morimoto RI (2013) Regulation of organismal proteostasis by trans-cellular chaperone signaling. Cell 153: 1366-1378. doi: 10.1016/j.cell.2013.05.015
    [219] Amaducci L, Tesco G (1994) Aging as a major risk for degenerative diseases of the central nervous system. Curr Opin Neurol 7: 283-286. doi: 10.1097/00019052-199408000-00001
    [220] David DC, Ollikainen N, Trinidad JC, et al. (2010) Widespread Protein Aggregation as an Inherent Part of Aging in C. elegans. PLoS Biol 8: e1000450. doi: 10.1371/journal.pbio.1000450
    [221] Cuervo AM, Dice JF (2000) Age-related decline in chaperone-mediated autophagy. J Biol Chem 275: 31505-31513. doi: 10.1074/jbc.M002102200
    [222] Tonoki A, Kuranaga E, Tomioka T, et al. (2009) Genetic Evidence Linking Age-Dependent Attenuation of the 26S Proteasome with the Aging Process. Mol Cell Biol 29: 1095-1106. doi: 10.1128/MCB.01227-08
    [223] Brehme M, Voisine C, Rolland T, et al. (2014) A Chaperome Subnetwork Safeguards Proteostasis in Aging and Neurodegenerative Disease. Cell Rep 9: 1135-1150. doi: 10.1016/j.celrep.2014.09.042
    [224] Ben-Zvi A, Miller EA, Morimoto RI (2009) Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A 106: 14914-14919 doi: 10.1073/pnas.0902882106
    [225] Kenyon C, Chang J, Gensch E, et al. (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366: 461-464.
    [226] Kenyon C (2001) A conserved regulatory system for aging. Cell 105: 165-168. doi: 10.1016/S0092-8674(01)00306-3
    [227] Giannakou ME, Partridge L (2007) Role of insulin-like signalling in Drosophila lifespan. Trends Biochem Sci 32: 180-188. doi: 10.1016/j.tibs.2007.02.007
    [228] Blüher M, Kahn BB, Kahn CR (2003) Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue. Science 299: 572-574. doi: 10.1126/science.1078223
    [229] Holzenberger M, Dupont J, Ducos B, et al. (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182-187. doi: 10.1038/nature01298
    [230] Taguchi A, Wartschow LM, White MF (2007) Brain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis. Science 317: 369-372. doi: 10.1126/science.1142179
    [231] Mair W, Dillin A (2008) Aging and Survival: The Genetics of Life Span Extension by Dietary Restriction. Annu Rev Biochem 77: 727-754. doi: 10.1146/annurev.biochem.77.061206.171059
    [232] Morris JZ, Tissenbaum HA, Ruvkun G (1996) A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382: 536-539. doi: 10.1038/382536a0
    [233] Henderson ST, Johnson TE (2001) daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol 11: 1975-1980. doi: 10.1016/S0960-9822(01)00594-2
    [234] Lee RY, Hench J, Ruvkun G (2001) Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr Biol 11: 1950-1957.
    [235] Lin K, Hsin H, Libina N, et al. (2001) Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28: 139-145. doi: 10.1038/88850
    [236] Lee SS, Kennedy S, Tolonen AC, et al. (2003) DAF-16 target genes that control C. elegans life-span and metabolism. Science 300: 644-647.
    [237] McElwee J, Bubb K, Thomas JH (2003) Transcriptional outputs of the Caenorhabditis elegans forkhead protein DAF-16. Aging Cell 2: 111-121. doi: 10.1046/j.1474-9728.2003.00043.x
    [238] Murphy CT, McCarroll SA, Bargmann CI, et al. (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424: 277-283. doi: 10.1038/nature01789
    [239] Wook Oh S, Mukhopadhyay A, Dixit BL, et al. (2006) Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation. Nat Genet 38: 251-257. doi: 10.1038/ng1723
    [240] Samuelson AV, Carr CE, Ruvkun G (2007) Gene activities that mediate increased life span of C. elegans insulin-like signaling mutants. Genes Dev 21: 2976-2994.
    [241] Tullet J (2008) Direct Inhibition of the Longevity-Promoting Factor SKN-1 by Insulin-like Signaling in C. elegans. Cell 132: 1025-1038. doi: 10.1016/j.cell.2008.01.030
    [242] Lithgow GJ, White TM, Melov S, et al. (1995) Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc Natl Acad Sci U S A 92: 7540-7544. doi: 10.1073/pnas.92.16.7540
    [243] Garigan D, Hsu A-L, Fraser AG, et al. (2002) Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics 161: 1101-1112.
    [244] Herndon LA, Schmeissner PJ, Dudaronek JM, et al. (2002) Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 419: 808-814. doi: 10.1038/nature01135
    [245] Hsu A-L, Murphy CT, Kenyon C (2003) Regulation of Aging and Age-Related Disease by DAF-16 and Heat-Shock Factor. Science 300: 1142-1145. doi: 10.1126/science.1083701
    [246] Kenyon C (2005) The plasticity of aging: insights from long-lived mutants. Cell 120: 449-460. doi: 10.1016/j.cell.2005.02.002
    [247] Tissenbaum HA, Ruvkun G (1998) An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 148: 703-717.
    [248] Honda Y, Honda S (1999) The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J 13: 1385-1393.
    [249] Scott BA, Avidan MS, Crowder CM (2002) Regulation of Hypoxic Death in C. elegans by the Insulin/IGF Receptor Homolog DAF-2. Science 296: 2388-2391.
    [250] Barsyte D, Lovejoy DA, Lithgow GJ (2001) Longevity and heavy metal resistance in daf-2 and age-1 long-lived mutants of Caenorhabditis elegans. FASEB J 15: 627-634. doi: 10.1096/fj.99-0966com
    [251] Garsin DA, Villanueva JM, Begun J, et al. (2003) Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 300: 1921.
    [252] Jellinger KA (2009) Recent advances in our understanding of neurodegeneration. J Neural Transm 116: 1111-1162. doi: 10.1007/s00702-009-0240-y
    [253] Ballard C, Gauthier S, Corbett A, et al. (2011) Alzheimer's disease. Lancet 377: 1019-1031. doi: 10.1016/S0140-6736(10)61349-9
    [254] Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373: 2055-2066. doi: 10.1016/S0140-6736(09)60492-X
    [255] Fan H-C, Ho L-I, Chi C-S, et al. (2014) Polyglutamine (PolyQ) diseases: genetics to treatments. Cell Transplant 23: 441-458. doi: 10.3727/096368914X678454
    [256] Ballinger CA, Connell P, Wu Y, et al. (1999) Identification of CHIP, a Novel Tetratricopeptide Repeat-Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone Functions. Mol Cell Biol 19: 4535-4545.
    [257] Walker LC, LeVine H (2012) Corruption and spread of pathogenic proteins in neurodegenerative diseases. J Biol Chem 287: 33109-33115. doi: 10.1074/jbc.R112.399378
    [258] Brignull HR, Moore FE, Tang SJ, et al. (2006) Polyglutamine Proteins at the Pathogenic Threshold Display Neuron-Specific Aggregation in a Pan-Neuronal Caenorhabditis elegans Model. J Neurosci 26: 7597-7606.
    [259] Wyttenbach A (2004) Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis. J Mol Neurosci 23: 69-96. doi: 10.1385/JMN:23:1-2:069
    [260] Yu A, Shibata Y, Shah B, et al. (2014) Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition. Proc Natl Acad Sci U S A 111: E1481-E1490. doi: 10.1073/pnas.1321811111
    [261] Morley JF, Brignull HR, Weyers JJ, et al. (2002) The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A 99: 10417-10422. doi: 10.1073/pnas.152161099
    [262] Teixeira-Castro A, Ailion M, Jalles A, et al. (2011) Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways. Hum Mol Genet 20: 2996-3009.
    [263] Warrick JM, Paulson HL, Gray-Board GL, et al. (1998) Expanded Polyglutamine Protein Forms Nuclear Inclusions and Causes Neural Degeneration in Drosophila. Cell 93: 939-949. doi: 10.1016/S0092-8674(00)81200-3
    [264] Warrick JM, Chan HYE, Gray-Board GL, et al. (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 23: 425-428. doi: 10.1038/70532
    [265] Chan HYE, Warrick JM, Gray-Board GL, et al. (2000) Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum Mol Genet 9: 2811-2820. doi: 10.1093/hmg/9.19.2811
    [266] Bonini NM (2002) Chaperoning brain degeneration. Proc Natl Acad Sci U S A 99 Suppl 4: 16407-16411.
    [267] Nollen EAA, Garcia SM, van Haaften G, et al. (2004) Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A 101: 6403-6408. doi: 10.1073/pnas.0307697101
    [268] Labbadia J, Novoselov SS, Bett JS, et al. (2012) Suppression of protein aggregation by chaperone modification of high molecular weight complexes. Brain J Neurol 135: 1180-1196. doi: 10.1093/brain/aws022
    [269] Van Ham TJ, Holmberg MA, van der Goot AT, et al. (2010) Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity. Cell 142: 601-612. doi: 10.1016/j.cell.2010.07.020
    [270] Falsone SF, Meyer NH, Schrank E, et al. (2012) SERF Protein Is a Direct Modifier of Amyloid Fiber Assembly. Cell Rep 2: 358-371. doi: 10.1016/j.celrep.2012.06.012
    [271] Labbadia J, Morimoto RI (2013) Huntington's disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 38: 378-385. doi: 10.1016/j.tibs.2013.05.003
    [272] Chafekar SM, Duennwald ML (2012) Impaired Heat Shock Response in Cells Expressing Full-Length Polyglutamine-Expanded Huntingtin. PLoS ONE 7: e37929. doi: 10.1371/journal.pone.0037929
    [273] Labbadia J, Cunliffe H, Weiss A, et al. (2011) Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J Clin Invest 121: 3306-3319. doi: 10.1172/JCI57413
    [274] Riva L, Koeva M, Yildirim F, et al. (2012) Poly-glutamine expanded huntingtin dramatically alters the genome wide binding of HSF1. J Huntingt Dis 1: 33-45.
    [275] Cohen E, Bieschke J, Perciavalle RM, et al. (2006) Opposing activities protect against age-onset proteotoxicity. Science 313: 1604-1610. doi: 10.1126/science.1124646
    [276] Huang S, Ling JJ, Yang S, et al. (2011) Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor. Brain J Neurol 134: 1943-1958. doi: 10.1093/brain/awr146
    [277] Olzscha H, Schermann SM, Woerner AC, et al. (2011) Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144: 67-78. doi: 10.1016/j.cell.2010.11.050
    [278] Cohen E, Paulsson JF, Blinder P, et al. (2009) Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 139: 1157-1169. doi: 10.1016/j.cell.2009.11.014
    [279] Jiang M, Wang J, Fu J, et al. (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med 18: 153-158.
    [280] Raynes R, Pombier KM, Nguyen K, et al. (2013) The SIRT1 Modulators AROS and DBC1 Regulate HSF1 Activity and the Heat Shock Response. PLoS ONE 8: e54364
    [281] Pratt WB, Gestwicki JE, Osawa Y, et al. (2015) Targeting hsp90/hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases. Annu Rev Pharmacol Toxicol 55: 353-371. doi: 10.1146/annurev-pharmtox-010814-124332
    [282] Auluck PK, Bonini NM (2002) Pharmacological prevention of Parkinson disease in Drosophila. Nat Med 8: 1185-1186. doi: 10.1038/nm1102-1185
    [283] Dou F, Netzer WJ, Tanemura K, et al. (2003) Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A 100: 721-726. doi: 10.1073/pnas.242720499
    [284] Batulan Z, Taylor DM, Aarons RJ, et al. (2006) Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis. Neurobiol Dis 24: 213-225. doi: 10.1016/j.nbd.2006.06.017
    [285] Fujikake N, Nagai Y, Popiel HA, et al. (2008) Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J Biol Chem 283: 26188-26197. doi: 10.1074/jbc.M710521200
    [286] Egorin MJ, Lagattuta TF, Hamburger DR, et al. (2002) Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats. Cancer Chemother Pharmacol 49: 7-19. doi: 10.1007/s00280-001-0380-8
    [287] Smith V, Sausville EA, Camalier RF, et al. (2005) Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models. Cancer Chemother Pharmacol 56: 126-137. doi: 10.1007/s00280-004-0947-2
    [288] Herbst M, Wanker EE (2007) Small Molecule Inducers of Heat-Shock Response Reduce polyQ-Mediated Huntingtin Aggregation. Neurodegener Dis 4: 254-260. doi: 10.1159/000101849
    [289] Tokui K, Adachi H, Waza M, et al. (2009) 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum Mol Genet 18: 898-910.
    [290] Silva-Fernandes A, Duarte-Silva S, Neves-Carvalho A, et al. (2014) Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease. Neurother J Am Soc Exp Neurother 11: 433-449. doi: 10.1007/s13311-013-0255-9
    [291] Waza M, Adachi H, Katsuno M, et al. (2005) 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med 11: 1088-1095. doi: 10.1038/nm1298
    [292] Thomas M, Harrell JM, Morishima Y, et al. (2006) Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction. Hum Mol Genet 15: 1876-1883. doi: 10.1093/hmg/ddl110
    [293] Wang L, Xie C, Greggio E, et al. (2008) The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J Neurosci 28: 3384-3391. doi: 10.1523/JNEUROSCI.0185-08.2008
    [294] Moriwaki Y, Kim Y-J, Ido Y, et al. (2008) L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner. Neurosci Res 61: 43-48. doi: 10.1016/j.neures.2008.01.006
    [295] Luo W, Dou F, Rodina A, et al. (2007) Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proc Natl Acad Sci U S A 104: 9511-9516. doi: 10.1073/pnas.0701055104
    [296] Dickey CA, Kamal A, Lundgren K, et al. (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest 117: 648-658. doi: 10.1172/JCI29715
    [297] Riedel M, Goldbaum O, Schwarz L, et al. (2010) 17-AAG Induces Cytoplasmic α-Synuclein Aggregate Clearance by Induction of Autophagy. PLoS ONE 5: e8753. doi: 10.1371/journal.pone.0008753
    [298] Chen Y, Wang B, Liu D, et al. (2014) Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment. J Neurosci 34: 2464-2470. doi: 10.1523/JNEUROSCI.0151-13.2014
    [299] Neef DW, Turski ML, Thiele DJ (2010) Modulation of Heat Shock Transcription Factor 1 as a Therapeutic Target for Small Molecule Intervention in Neurodegenerative Disease. PLoS Biol 8: e1000291
    [300] Neef DW, Jaeger AM, Gomez-Pastor R, et al. (2014) A direct regulatory interaction between chaperonin TRiC and stress-responsive transcription factor HSF1. Cell Rep 9: 955-966. doi: 10.1016/j.celrep.2014.09.056
    [301] Calamini B, Silva MC, Madoux F, et al. (2012) Small-molecule proteostasis regulators for protein conformational diseases. Nat Chem Biol 8: 185-196.
    [302] Shoulders MD, Ryno LM, Cooley CB, et al. (2013) Broadly Applicable Methodology for the Rapid and Dosable Small Molecule-Mediated Regulation of Transcription Factors in Human Cells. J Am Chem Soc 135: 8129-8132. doi: 10.1021/ja402756p
    [303] Ryno LM, Genereux JC, Naito T, et al. (2014) Characterizing the Altered Cellular Proteome Induced by the Stress-Independent Activation of Heat Shock Factor 1. ACS Chem Biol 9: 1273-1283. doi: 10.1021/cb500062n
    [304] Calamini B, Morimoto RI (2012) Protein homeostasis as a therapeutic target for diseases of protein conformation. Curr Top Med Chem 12: 2623-2640
  • This article has been cited by:

    1. Moshe Rosenberg, Yael Rosenberg, Proteolysis during aging of commercial full-fat and reduced-fat Cheddar cheeses of identical chronological age, 2022, 7, 2471-2086, 855, 10.3934/agrfood.2022052
  • Reader Comments
  • © 2015 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(9970) PDF downloads(1492) Cited by(2)

Figures and Tables

Figures(5)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog